pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
zatolmilast
Fragile X Syndrome
3',5'-cyclic-AMP phosphodiesterase 4D
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Marketed
zavegepant hydrochloride
Zavzpret (zavegepant hydrochloride)
Migraine
$PFE
PFIZER INC
0
catalysts
Phase 1
zavondemstat
zavondemstat [INN]
Gastrointestinal Tumor
Tachyon Therapeutics Inc
← prev
page 230 of 231
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 2
zegocractin
Pancreatitis
$CALC
CalciMedica, Inc.
0
catalysts
Phase 1
zelebrudomide
Diffuse Large B-Cell Lymphoma
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
Phase 2
zeleciment basivarsen
Myotonic Dystrophy
$DYN
Dyne Therapeutics, Inc.
0
catalysts
Phase 2
zeleciment rostudirsen
Duchenne Muscular Dystrophy
$DYN
Dyne Therapeutics, Inc.
0
catalysts
Phase 2
zelenirstat
zelenirstat [INN]
Refractory Acute Myeloid Leukemia
Pacylex Pharmaceuticals Inc
0
catalysts
Phase 2
zelicapavir
Respiratory Syncytial Virus (RSV) Infections
$ENTA
ENANTA PHARMACEUTICALS INC
0
catalysts
Phase 2
zelquistinel
zelquistinel [INN]
Major Depressive Disorder
Syndeio Biosciences Inc
0
catalysts
Phase 2
zemocimig
zemocimig [INN]
Hemophilia A (Factor VIII Deficiency)
F. Hoffmann-La Roche Ltd
0
catalysts
pre_registration
zenocutuzumab
Bizengri (zenocutuzumab-zbco)
Bile Duct Cancer (Cholangiocarcinoma)
ErbB-2/ErbB-3 heterodimer
Merus NV
0
catalysts
Phase 2
zenuzolac
zenuzolac [INN]
Coronavirus Disease 2019 (COVID-19) Pneumonia
GeneOne Life Science Inc
0
catalysts
Phase 2
zerlasiran sodium
Atherosclerosis
$SLN
Silence Therapeutics plc
0
catalysts
Phase 2
zervimesine
Elayta (zervimesine)
Alzheimer's Disease
$CGTX
COGNITION THERAPEUTICS INC
0
catalysts
Phase 2
zetomipzomib maleate
Autoimmune Hepatitis
$KZR
Kezar Life Sciences, Inc.
0
catalysts
Preclinical
zevaquenabant
zevaquenabant [INN]
Systemic Sclerosis (Scleroderma)
Scopus BioPharma Inc
0
catalysts
Phase 2
zevotrelvir
Coronavirus Disease 2019 (COVID-19)
$ENTA
ENANTA PHARMACEUTICALS INC
0
catalysts
Marketed
ziconotide
Prialt (ziconotide)
Pain
Esteve Pharmaceuticals SA
0
catalysts
pre_registration
zidesamtinib
Non-Small Cell Lung Cancer
$NUVL
Nuvalent, Inc.
0
catalysts
Marketed
zidovudine
Retrovir (zidovudine)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
ViiV Healthcare Company
0
catalysts
Phase 1
zifanocycline
zifanocycline [INN]
Acinetobacter Infections
KBP Biosciences Co Ltd
0
catalysts
Phase 3
zifogaptide acetate
Granexin (zifogaptide acetate)
Radiation Injury
Xequel Bio Inc
0
catalysts
Marketed
ziftomenib
Komzifti (ziftomenib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$KURA
Kura Oncology, Inc.
0
catalysts
Phase 3
zilebesiran sodium
Hypertension
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
0
catalysts
Marketed
zileuton CR
Zileuton Prasco (zileuton)
Asthma
Prasco LLC
0
catalysts
pre_registration
zilganersen sodium
Alexander Disease
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
zilovertamab vedotin
zilovertamab vedotin [INN]
Mantle Cell Lymphoma
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
zilurgisertib fumarate
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)
$INCY
INCYTE CORP
0
catalysts
Phase 2
zimberelimab
Adenocarcinoma Of The Gastroesophageal Junction
Programmed cell death protein 1
$RCUS
Arcus Biosciences, Inc.
0
catalysts
